IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
about
Requirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/TxkThe Phox homology (PX) domain, a new player in phosphoinositide signallingRegulatory and signaling properties of the Vav familyStructural basis of interleukin-5 dimer recognition by its α receptorIsolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3Protein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinasesThe Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent mannerFunctional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cellsDifferential biological activity of disease-associated JAK2 mutantsIdentification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse BtkInterleukin-5 and IL-5 receptor in health and diseasesBruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases.IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis.Bruton's tyrosine kinase and protein kinase C µ are required for TLR7/9-induced IKKα and IRF-1 activation and interferon-β production in conventional dendritic cellsIdentification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control regionThe intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathwayInvolvement of p59fynT in interleukin-5 receptor signaling.Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production.Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation.A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.A functional bipartite nuclear localisation signal in the cytokine interleukin-5.Cytokine signaling in the differentiation of innate effector cellsIL-5- and eosinophil-mediated inflammation: from discovery to therapy.Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases.Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.Th2 cytokine antagonists: potential treatments for severe asthma.Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness.Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.Regulation of Btk by Src family tyrosine kinases.Biology of interleukin-5 and its relevance to allergic disease.The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro.Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.
P2860
Q21263140-6FBDC050-40EF-433D-A214-2DCE932F60F2Q24533547-002C57A2-F7C8-4D8A-96DF-EDD2F8F5111AQ24554307-1461DC77-590A-478C-9B27-5BBB02BCA860Q27678698-4E15F8C4-45AF-48EB-89C2-826E5F8E4EA5Q28139753-C898441B-2E8B-4727-A4B3-D72031982021Q28140037-86DE1209-D95F-4358-B47E-B955222330DCQ28144756-49DEA254-54B4-4C39-9EF4-84C0E6C17F4CQ28362341-8A4D676A-D8FE-4809-8BF3-9079C5E944FFQ28508045-C5C935EF-BBBD-4908-A16F-849704C5F30FQ28590209-09D1FA87-7B63-49FB-A553-518306F53AD7Q28730921-413E0C92-494F-4F0C-9DE5-4458D79D5561Q30429683-D6E8BB54-E5A6-4B85-BE82-3C9B13265A61Q33707566-778263AB-F670-4D68-90E3-0C7266B20B00Q33725816-872A29F6-CE0F-415F-A81C-4A2197793297Q33869434-33E65BB0-7804-42A7-A658-4334591BA4BBQ33941375-FD15A6C4-9CA3-433C-B902-33B0DE6CC4ECQ33959940-03392ADC-8EE3-45C0-9209-F00B989BEB24Q34110344-CBEFE23B-EA76-4C29-8904-C50161456E06Q34409699-E122854F-157F-4E2F-BA62-30352A7EA2EAQ35908626-53716AFD-E089-4517-B60E-365C9B75D2CDQ35957766-BF1DE3DC-B761-4969-92DD-C06E3BECF234Q36364828-A43C9068-DAC5-45E3-B598-C4B8B4D9BC01Q36365319-98A78D9B-F09D-477A-AAF2-6674FF85E68AQ36400671-3D3BEFB9-24B6-4081-8081-095B51C56886Q36401490-BA363CEC-1C3D-4102-84BA-8615449DF9B1Q36585953-9204BA40-FB28-4A14-8D9E-FBBD17D8E3FFQ36601174-1DEE8A50-A1BD-4861-984F-0C650B5C6E08Q36858506-A7DC1F85-72B7-4739-9383-B5D62C607E83Q36895427-637F1555-6E81-401D-A329-C8E62FBE0184Q37612636-278BE828-98EC-44B9-9028-BAF68C954398Q37620959-EEE34281-35C4-415D-AE52-7664E5D87D28Q37957225-8C609E6C-ACF1-401E-8BF7-C582D4489A54Q38057796-E3CA93E2-1CAB-4467-BC22-59BB924D57F9Q38515481-9B7174E3-DA03-4D58-AB78-09A3D3F3135BQ40017947-C7B57A31-8FBE-4518-93CC-BA90ECD9E30AQ40019232-473C51DC-B95B-4426-B375-41438E911EC5Q41062106-C1711F51-13F7-4008-9499-63141EFB3988Q41103584-C4D2225C-DD1B-4760-9B09-5DB4C62CD00EQ42943439-9FFE9536-51FD-462C-8502-2DB0AEFCCD6CQ45870581-606A0DE0-9554-4AF1-AEE3-1A3A3BDC67B0
P2860
IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@ast
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@en
type
label
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@ast
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@en
prefLabel
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@ast
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@en
P2093
P2860
P356
P1476
IL-5 receptor-mediated tyrosin ...... tyrosine and Janus 2 kinases.
@en
P2093
D Kitamura
S Yonehara
T Katagiri
T Watanabe
P2860
P304
P356
10.1084/JEM.180.6.2101
P407
P577
1994-12-01T00:00:00Z